glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with Bone Loss, Osteoclastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baas, C; de Groot, H; Löwik, C; Mouthaan, H; Papapoulos, S; van der Pluijm, G | 1 |
Markland, F; Mercer, B; Minkin, C | 1 |
2 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and Bone Loss, Osteoclastic
Article | Year |
---|---|
Integrins and osteoclastic resorption in three bone organ cultures: differential sensitivity to synthetic Arg-Gly-Asp peptides during osteoclast formation.
Topics: Amino Acid Sequence; Animals; Bone Resorption; Calcium; Dose-Response Relationship, Drug; Female; Integrins; Intercellular Signaling Peptides and Proteins; Mice; Oligopeptides; Organ Culture Techniques; Osteoclasts; Peptides; Pregnancy; Viper Venoms | 1994 |
Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Bone Resorption; Cattle; Cell Adhesion; Crotalid Venoms; Disintegrins; Extracellular Matrix; Fetal Blood; Integrin beta3; Oligopeptides; Osteoclasts; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Vitronectin; Vitronectin | 1998 |